| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.62B | +6.5% |
| Cost of Revenue | $19.17B | +10.6% |
| R&D Expense | $2.71B | +19.2% |
| SG&A Expense | $1.57B | +16.4% |
| Operating Income | $5.63B | -9.1% |
| Interest Expense | $706.2M | -7.8% |
| Pre-tax Income | $5.26B | -9.9% |
| Income Tax | $772.0M | +6.6% |
| Net Income | $4.49B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.15B | -14.6% |
| Short-term Investments | $911.3M | — |
| Current Assets | $9.27B | +14.8% |
| Total Assets | $48.59B | +9.0% |
| Current Liabilities | $7.93B | -6.6% |
| Long-term Debt | $14.35B | -2.3% |
| Total Liabilities | $27.82B | -3.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.03B | +416.1% |
| Capital Expenditures | $407.7M | -22.3% |
| Investing Cash Flow | -$2.08B | -55.0% |
| Financing Cash Flow | -$664.3M | +42.2% |
| Free Cash Flow | $1.62B | +1326.4% |
| -12.2% |
| EPS (Basic) | $10.10 | -12.6% |
| EPS (Diluted) | $9.95 | -11.5% |
| Stockholders' Equity |
| $20.78B |
| +31.1% |